Chemistry Wealth Management’s Royal Bank of Canada RY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$444K Sell
2,146
-285
-12% -$52.9K 0.07% 139
2026
Q1
$393K Sell
2,431
-437
-15% -$73.1K 0.07% 143
2025
Q4
$489K Hold
2,868
0.09% 119
2025
Q3
$423K Hold
2,868
0.08% 130
2025
Q2
$377K Sell
2,868
-175
-6% -$21.4K 0.08% 126
2025
Q1
$343K Hold
3,043
0.08% 125
2024
Q4
$367K Sell
3,043
-330
-10% -$40.7K 0.09% 120
2024
Q3
$421K Sell
3,373
-117
-3% -$13.4K 0.1% 113
2024
Q2
$371K Sell
3,490
-501
-13% -$51.5K 0.1% 113
2024
Q1
$403K Sell
3,991
-312
-7% -$30.8K 0.11% 109
2023
Q4
$435K Sell
4,303
-400
-9% -$35.2K 0.13% 100
2023
Q3
$411K Sell
4,703
-257
-5% -$23.9K 0.14% 95
2023
Q2
$474K Sell
4,960
-150
-3% -$14.3K 0.15% 90
2023
Q1
$488K Hold
5,110
0.17% 91
2022
Q4
$480K Hold
5,110
0.19% 82
2022
Q3
$460K Hold
5,110
0.18% 87
2022
Q2
$495K Sell
5,110
-385
-7% -$39.4K 0.19% 86
2022
Q1
$606K Buy
+5,495
New +$616K 0.21% 73

Other funds holding RY

Chemistry Wealth Management's RY Position: Q2 2026 in Review

Chemistry Wealth Management reduced its Royal Bank of Canada (RY) stake by 12% in Q2 2026, selling an estimated $52.9K and leaving 2,146 shares worth $444K. The position accounts for 0.07% of the portfolio, ranked #139.

Chemistry Wealth Management first reported a position in RY in Q1 2022 and has held it in 18 quarters since. The position peaked at $606K in Q1 2022. 204 funds tracked by Wall St. Rank hold RY as of Q2 2026.

  • Chemistry Wealth Management held 2,146 shares of Royal Bank of Canada worth $444K as of Q2 2026.
  • Chemistry Wealth Management sold 285 Royal Bank of Canada shares in Q2 2026, an estimated $52.9K.
  • Royal Bank of Canada made up 0.07% of Chemistry Wealth Management's portfolio in Q2 2026, its #139 holding.
  • Chemistry Wealth Management first reported a position in Royal Bank of Canada in Q1 2022 and has held it in 18 quarters since.
  • Chemistry Wealth Management's Royal Bank of Canada position peaked at $606K in Q1 2022.
  • 204 funds tracked by Wall St. Rank held Royal Bank of Canada as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.